Related Pages Prostate Cancer Home Page NCI's gateway for information about prostate cancer.

About SELECT
Selenium and Vitamin E Cancer Prevention Trial (SELECT): Questions and Answers
(Reviewed: 06/13/2005) - A fact sheet that describes a clinical trial designed to determine if selenium and/or vitamin E can prevent prostate cancer. National Cancer Institute Fact Sheet 4.20

Largest-Ever Prostate Cancer Prevention Trial Opens: 32,000 Men Sought to Test Vitamin E and Selenium
(Posted: 07/24/2001) - Healthy men age 55 and older are needed for the largest-ever prostate cancer prevention study, launched today by the NCI and a network of researchers known as the Southwest Oncology Group (SWOG). Questions and Answers

Phase III Randomized Study of Selenium and Vitamin E for the Prevention of Prostate Cancer (SELECT Trial)
A summary of the SELECT protocol statement.

SELECT Data: Enrollment Statistics
(Updated: 09/04/2003) - Enrollment data from SELECT, the Selenium and Vitamin E Cancer Prevention Trial.
About SELECT (Español)
Estudio del Selenio y la Vitamina E para Prevenir el Cáncer (SELECT): preguntas y respuestas
(Revisión: 06/28/2005) - Esta es la versión en español de una hoja informativa que responde preguntas acerca de un estudio clínico para ver si el selenio o la vitamina previenen el cáncer de próstata. Hoja informativa 4.20s del Instituto Nacional del Cáncer/This is the Spanish version of a fact sheet that answers questions about a clinical trial to see if Selenium or Vitamin E prevent prostate cancer in men. National Cancer Institute Fact Sheet 4.20s

Se inagura estudio de prevención de cáncer de próstata
(Publicación: 07/24/2001) - Más de 400 centros en los Estados Unidos, Puerto Rico y Canadá están aceptando participantes para SELECT. Este estudio durará 12 años. SELECT es el primer estudio diseñado para observar directamente los efectos del selenio y la vitamina E, tanto juntos como por separado, para prevenir el cáncer de próstata.
About Other Prostate Cancer Prevention Trials
Prostate Cancer Prevention Trial (PCPT): Questions and Answers
(Posted: 06/24/2003, Updated: 05/18/2008) - In the Prostate Cancer Prevention Trial (PCPT), 25 percent fewer men taking the drug finasteride developed prostate cancer than men not taking the drug. However, men who developed prostate cancer while taking finasteride were more likely to have high-grade cancers, which can spread quickly even if the tumors are small.
About Other Vitamin E Trials
HOPE-TOO: NCI Comment on Published Results
(Posted: 03/15/2005) - A report published in the March 16 issue of the Journal of the American Medical Association finds no clear evidence that men and women who had vascular disease or diabetes and who took 400 i.u. of vitamin E daily for 7 years reduced their risk of cancer compared to others with these conditions who took a placebo.
About Prostate Cancer Prevention
Prostate Cancer Prevention (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about factors that may influence the risk of developing prostate cancer and about research aimed at the prevention of this disease.

Best Leads for Prostate Cancer Prevention Appear in April Urology Supplement; Agents, Biomarker Endpoints, Cohorts, and Trial Designs Outlined
(Posted: 04/09/2001) - The most promising agents to prevent prostate cancer and the most likely biological markers of risk for the disease are just two of the key areas of prostate cancer prevention research highlighted.

< Previous Section  |  Next Section >